Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
46(5):483-93
Post hoc analysis shows that the group treated with 200 μM BMS-5 express lower freezing levels compared to the 20 μM and vehicle groups (P<0
LDN-212854 exhibits some selectivity for ALK2 in preference to other BMP type I receptors
11(11):2499-507
DVT's may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients
SB525334 - CAS# 356559-20-1 Catalog No.:M6900-2 46(5):483-93SB525334, CAS No. 356559 20 1, is a potent and selective inhibitor of the transforming growth factor beta1 (TGF beta1) receptor, activin receptor like kinase (ALK5). SB525334 inhibited ALK5 kinase activity with an IC(50) of 14. 3 nM and was approximately 4 fold less potent as an inhibitor of ALK4 (IC(50) = 58. 5 nM). SB 525334 was inactive as an inhibitor of ALK2, ALK3, and ALK6 (IC(50) > 10, 000 nM). In cell based assays, SB 525334 (1 microM) blocked